On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer short-term pain relief for people with complex regional pain syndrome (CRPS ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Individualized treatment for osteoporosis calls for a keen understanding of the patient’s frame ...

(Reuters Health) - Older women with osteoporosis who consistently take medications for the condition may have a lower risk of fractures and lower total health costs than their counterparts who stop ...

In a world where an aging population faces increasing health challenges, a silent epidemic is quietly eroding the quality of life for millions. Osteoporosis affects one in three women and one in five ...

Vitamin D3 may be one exception as it is important to prevent and treat osteoporosis for those who are at risk. While I often ...

NEW YORK (Reuters) - Women who took a commonly used class of osteoporosis drugs called bisphosphonates had significantly fewer invasive breast cancers than women not using the bone-strengthening pills ...

Learn about osteoporosis, its risks, symptoms, and prevention strategies to maintain bone health and prevent fractures.

Dr. Reddy’s and Alvotech shared that the Food and Drug Administration has accepted a 351(k) Biologic License Application submission for AVT03, which was developed by Alvotech, and is a proposed ...